These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20493001)

  • 1. Dendritic release of substances in the substantia nigra.
    Glowinski J
    Neurochem Int; 1985; 7(6):903-4. PubMed ID: 20493001
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent.
    Cobb WS; Abercrombie ED
    Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra.
    Nedergaard S; Bolam JP; Greenfield SA
    Nature; 1988 May; 333(6169):174-7. PubMed ID: 2897080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raphé nucleus-evoked release of acetylcholinesterase from guinea-pig substantia nigra.
    Dickie BG; Greenfield SA
    Neuroreport; 1994 Mar; 5(7):769-72. PubMed ID: 8018847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.
    Elverfors A; Pileblad E; Lagerkvist S; Bergquist F; Jonason J; Nissbrandt H
    J Neurochem; 1997 Oct; 69(4):1684-92. PubMed ID: 9326297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of local administration of L-, N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra: a microdialysis study in rat.
    Bergquist F; Jonason J; Pileblad E; Nissbrandt H
    J Neurochem; 1998 Apr; 70(4):1532-40. PubMed ID: 9523570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.
    Arbilla S; Kamal LA; Langer SZ
    Br J Pharmacol; 1981 Oct; 74(2):389-97. PubMed ID: 7317688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of acetylcholinesterase in the rat nigrostriatal pathway: relation to receptor activation and firing rate.
    Weston J; Greenfield SA
    Neuroscience; 1986 Apr; 17(4):1079-88. PubMed ID: 3714040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo presynaptic control of dopamine release in the cat caudate nucleus--I. Opposite changes in neuronal activity and release evoked from thalamic motor nuclei.
    Romo R; Chéramy A; Godeheu G; Glowinski J
    Neuroscience; 1986 Dec; 19(4):1067-79. PubMed ID: 3029624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.
    Heeringa MJ; Abercrombie ED
    J Neurochem; 1995 Jul; 65(1):192-200. PubMed ID: 7790860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.
    Andersson DR; Björnsson E; Bergquist F; Nissbrandt H
    Exp Neurol; 2010 Jan; 221(1):251-9. PubMed ID: 19944096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
    Faggin BM; Zubieta JK; Rezvani AH; Cubeddu LX
    J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.
    Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J
    Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
    Lindefors N; Brodin E; Tossman U; Segovia J; Ungerstedt U
    Exp Brain Res; 1989; 74(3):527-34. PubMed ID: 2468514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic stimulation of rostral and caudal substantia nigra pars compacta produces opposite effects on circling behavior and striatal dopamine release measured by brain microdialysis.
    Hernández-López S; Góngora-Alfaro JL; Martínez-Fong D; Rosales MG; Aceves J
    Neuroscience; 1994 Sep; 62(2):441-7. PubMed ID: 7830890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats.
    Lu X; Bing G; Hagg T
    Neuroscience; 2000; 97(2):285-91. PubMed ID: 10799760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal initiation and active dendritic propagation of action potentials in substantia nigra neurons.
    Häusser M; Stuart G; Racca C; Sakmann B
    Neuron; 1995 Sep; 15(3):637-47. PubMed ID: 7546743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendro-dendritic synapses in substantia nigra: descriptions based on analysis of serial sections.
    Groves PM; Linder JC
    Exp Brain Res; 1983; 49(2):209-17. PubMed ID: 6832258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo release of dopamine during perfusion of neurotensin in substantia nigra of the unrestrained rat.
    Myers RD; Lee TF
    Peptides; 1983; 4(6):955-61. PubMed ID: 6672795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity.
    You ZB; Herrera-Marschitz M; Pettersson E; Nylander I; Goiny M; Shou HZ; Kehr J; Godukhin O; Hökfelt T; Terenius L; Ungerstedt U
    Neuroscience; 1996 Oct; 74(3):793-804. PubMed ID: 8884775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.